LOUIS J LAVIGNE JR Insider Trading $DNA GENENTECH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOUIS J LAVIGNE JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOUIS J LAVIGNE JR. LOUIS J LAVIGNE JR is Director in ALLERGAN INC ($AGN) and EVP and CFO in GENENTECH INC ($DNA) and Director in DEPOMED INC ($DMI) and Director in ACCURAY INC ($ARAY) and Director in DOCUSIGN INC ($DOCU) and Director in ZYNGA INC ($ZNGA) and Director in Novocure Ltd ($NVCR) and Director in Alector, Inc. ($ALEC).
LOUIS J LAVIGNE JR in GENENTECH INC
Trading Symbol: DNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS J LAVIGNE JR: EVP and CFO
Holdings: 2,765 shares
Latest Transaction: Jul 29 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LOUIS J LAVIGNE JR in GENENTECH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAY, ALEC, AGN, DMI, DOCU, DNA, NVCR, ZNGA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,600 | 38,800 | 400,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,200 | 29,100 | 401,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 402,800 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 600 | 14,550 | 403,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 400 | 9,700 | 403,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,400 | 33,950 | 404,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.10 | 1,600 | 126,560 | 2,765 | 4.4 K to 2.8 K (-36.66 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,600 | 38,800 | 4,365 | 2.8 K to 4.4 K (+57.87 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.09 | 1,200 | 94,908 | 2,765 | 4 K to 2.8 K (-30.26 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,200 | 29,100 | 3,965 | 2.8 K to 4 K (+43.40 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.08 | 200 | 15,816 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.05 | 600 | 47,430 | 2,765 | 3.4 K to 2.8 K (-17.83 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 600 | 14,550 | 3,365 | 2.8 K to 3.4 K (+21.70 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.03 | 400 | 31,612 | 2,765 | 3.2 K to 2.8 K (-12.64 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 400 | 9,700 | 3,165 | 2.8 K to 3.2 K (+14.47 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.02 | 1,400 | 110,628 | 2,765 | 4.2 K to 2.8 K (-33.61 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,400 | 33,950 | 4,165 | 2.8 K to 4.2 K (+50.63 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,700 | 65,475 | 405,400 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 20,700 | 501,975 | 408,100 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 428,800 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 700 | 16,975 | 429,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,000 | 48,500 | 429,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,900 | 70,325 | 431,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 100 | 2,425 | 434,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,300 | 31,525 | 434,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 100 | 2,425 | 436,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 436,100 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.01 | 2,700 | 213,327 | 2,765 | 5.5 K to 2.8 K (-49.41 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,700 | 65,475 | 5,465 | 2.8 K to 5.5 K (+97.65 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.00 | 20,700 | 1,635,300 | 2,765 | 23.5 K to 2.8 K (-88.22 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 20,700 | 501,975 | 23,465 | 2.8 K to 23.5 K (+748.64 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.90 | 200 | 15,580 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.89 | 700 | 54,523 | 2,765 | 3.5 K to 2.8 K (-20.20 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 700 | 16,975 | 3,465 | 2.8 K to 3.5 K (+25.32 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.87 | 2,000 | 155,740 | 2,765 | 4.8 K to 2.8 K (-41.97 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,000 | 48,500 | 4,765 | 2.8 K to 4.8 K (+72.33 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.85 | 2,900 | 225,765 | 2,765 | 5.7 K to 2.8 K (-51.19 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,900 | 70,325 | 5,665 | 2.8 K to 5.7 K (+104.88 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.84 | 100 | 7,784 | 2,765 | 2.9 K to 2.8 K (-3.49 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 100 | 2,425 | 2,865 | 2.8 K to 2.9 K (+3.62 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.80 | 1,300 | 101,140 | 2,765 | 4.1 K to 2.8 K (-31.98 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,300 | 31,525 | 4,065 | 2.8 K to 4.1 K (+47.02 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.79 | 100 | 7,779 | 2,765 | 2.9 K to 2.8 K (-3.49 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 100 | 2,425 | 2,865 | 2.8 K to 2.9 K (+3.62 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.75 | 200 | 15,550 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 436,300 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,700 | 65,475 | 436,500 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 439,200 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 800 | 19,400 | 439,400 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 400 | 9,700 | 440,200 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 5,500 | 133,375 | 440,600 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 28,100 | 681,425 | 446,100 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,000 | 24,250 | 474,200 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 500 | 12,125 | 475,200 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 600 | 14,550 | 475,700 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 476,300 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 700 | 16,975 | 476,500 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 300 | 7,275 | 477,200 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,500 | 60,625 | 477,500 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.59 | 200 | 15,918 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.56 | 2,700 | 214,812 | 2,765 | 5.5 K to 2.8 K (-49.41 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,700 | 65,475 | 5,465 | 2.8 K to 5.5 K (+97.65 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.54 | 200 | 15,908 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.53 | 800 | 63,624 | 2,765 | 3.6 K to 2.8 K (-22.44 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 800 | 19,400 | 3,565 | 2.8 K to 3.6 K (+28.93 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.52 | 400 | 31,808 | 2,765 | 3.2 K to 2.8 K (-12.64 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 400 | 9,700 | 3,165 | 2.8 K to 3.2 K (+14.47 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.51 | 5,500 | 437,305 | 2,765 | 8.3 K to 2.8 K (-66.55 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 5,500 | 133,375 | 8,265 | 2.8 K to 8.3 K (+198.92 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.50 | 28,100 | 2,233,950 | 2,765 | 30.9 K to 2.8 K (-91.04 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 28,100 | 681,425 | 30,865 | 2.8 K to 30.9 K (+1,016.27 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.49 | 1,000 | 79,490 | 2,765 | 3.8 K to 2.8 K (-26.56 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,000 | 24,250 | 3,765 | 2.8 K to 3.8 K (+36.17 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.41 | 500 | 39,705 | 2,765 | 3.3 K to 2.8 K (-15.31 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 500 | 12,125 | 3,265 | 2.8 K to 3.3 K (+18.08 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.40 | 600 | 47,640 | 2,765 | 3.4 K to 2.8 K (-17.83 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 600 | 14,550 | 3,365 | 2.8 K to 3.4 K (+21.70 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.39 | 200 | 15,878 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.38 | 700 | 55,566 | 2,765 | 3.5 K to 2.8 K (-20.20 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 700 | 16,975 | 3,465 | 2.8 K to 3.5 K (+25.32 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.36 | 300 | 23,808 | 2,765 | 3.1 K to 2.8 K (-9.79 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 300 | 7,275 | 3,065 | 2.8 K to 3.1 K (+10.85 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.35 | 2,500 | 198,375 | 2,765 | 5.3 K to 2.8 K (-47.48 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,500 | 60,625 | 5,265 | 2.8 K to 5.3 K (+90.42 %) |
Page: 1